Navigation Links
HIV Treatment Needs Re-Evaluation

A study published by scientists from California University in the Journal of Virology has showed that HIV treatment needs re-evaluation//. Scientist have discovered that the virus evaded the action of antiretroviral therapy (ARV) by hiding in intestinal tissue of patients, where it continued to replicate and suppress the immune system, even though blood samples showed that the antiretrovirals were working.

Professor Satya Dandekar, head of the University’s Department of Medical Microbiology and Immunology, who led the study has said that treatment should be focused more on improving the gut mucosa, as gut mucosa accounted for 70% of the body’s immune system, and that the real battle between the virus and affected individual is taking place there immediately after the infection.

The study also revealed that in patient with chronic infection the gut acted as a viral reservoir making the restoration of gut mucosal immune system tougher and longer than when diagnosed earlier and treated with ARV and anti-inflammatory drugs. The study urges gut biopsies in all patients receiving treatment to monitor their condition.

Thomas Prindiville, Gastroenterology professor and co-author of the study, has said that starting the treatment earlier helps restore the guts immune response and accelerates recovery.

The scientists observed that in patients receiving highly active antiretroviral therapy (HAART) within weeks of exposure the recovery of the gut immune system was better than in patients with chronic infection.


'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: HIV Treatment Needs Evaluation

(Date:7/9/2008)... DRE, Inc., a premier international ...ts customers that as much as $250,000 in medical e...e tax filings. , Louisvil...us Act of 2008, in accordance with Tax Code Sectio...equipment bought in 2008. This could make 2008 an ...
(Date:7/9/2008)... While SmartLipo has swept the natio...popular fat removal procedure has leaped forward. ...privileged to be the first in his state to offer t...lard is also one of only two plastic surgeons auth...is procedure. , Lone Tree...
(Date:7/8/2008)...ON, July 8 /PRNewswire-USNewswire/ -- The Justice ...ettlement with the Medical Weight,Loss Clinic, whi...e,Americans with Disabilities Act (ADA). It was al...erve a prospective client because she has HIV,dise...al Weight Loss Clinic will,provide training on the...
(Date:7/8/2008)... SKINTASTIC™ is pleased to a...®--the latest injectable collagen filler in th...uty treatments. EVOLENCE® utilizes highly-puri...red medical grafting substance due to its nearly i... N. Dallas/Plano, TX (PRWEB) July 8...
Breaking Medicine News(10 mins):Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 2Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 3Health News:Justice Department Reaches Settlement Agreement With Medical Weight Loss Clinic 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 3
...igan, made a new study which showed that an odd ...neck surgery. Ann Arbor say leeches are an effecti...s.Patients who have surgery// to remove cancer in ...d to have tissue transfers performed. Doctors say ...
...researchers have found that the bone marrow cell t...rchers in the US have been studying the ability of...s - to restore function in brain-damaged rats. Ani...s, which came from healthy human volunteers. Comp...
...enes appear to be able to delete sections of DNA, ...nd implications for the evolution of the human gen...A called Line 1 elements jumped around, inserted t...ve effects,// but this is the first time it has be...
...a baby's birth weight is connected to the mother's...lso shows women with the lightest and heaviest off....// More than 4,100 women ages between 62 and 75 y...chers found, as birth weight increased every 2.2 l...
Other Medicine News:Health News:Jumping genes eliminate sections of DNA 2
(Date:7/3/2008)...wire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MDVN...nce at 5:00,p.m. EDT on Monday, July 7, to discuss...d, placebo-controlled Phase 2 clinical trial of,di...e/Webcast Details, To participate in the live cal...telephone, please dial 877-419-6590 from the U.S. ...
(Date:7/3/2008)...RIDGE Massachusetts, July 3,/PRNewswire-FirstCall/...ogy company, Jerini AG for an equity purchase pri... (HAE) product, FIRAZYR(R), to its Human Genetic T...lobal sales expected to be around $350-400 millio... environment, - Expected to be accretive for Non ...
(Date:7/1/2008)...cation Newsletter Series for Healthcare ...July 1 /- Clostridium difficile infec...ase with a wide spectrum of,severity, ranging from...th.,Recurrent CDI can occur in up to 20% of patien...tients are at increased risk of additional,recurre...
(Date:7/1/2008)... for ,buying time, in victims of lethal ...- For the first time, researchers hav...mounts of inhaled or,intravenous hydrogen sulfide,...ir sulfurous stench -- significantly improves surv...gist Mark B. Roth, Ph.D., and colleagues in the Ba...
Breaking Medicine Technology:Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 2'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 3CME LLC Granted Five Year Full Approval by the American Psychological Association 4469 1CME LLC Granted Five Year Full Approval by the American Psychological Association 4469 2Immunosyn Corporation to Present at FSX 1465 1Immunosyn Corporation to Present at FSX 1465 2Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 1Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 2Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 3ABCs Private Practice Inaccurately Portrays Serious Womens Health Condition 1461 1ABCs Private Practice Inaccurately Portrays Serious Womens Health Condition 1461 2
...mends clinical utilization management,programs, ST...macy benefit,manager Prime Therapeutics (Prime) to...ation of Strattera(R) (atomoxetine) for treating,a...children. The,study found that children who start ...their therapy than children who started on,stimula...
...eclinical data for potential combination,therapies... after,ITMN-191 exposure, BARCELONA, Spain, April ... announced today the presentation of findings from...tease inhibitor,ITMN-191, alone or in combination ...f the European Association for the Study of the,Li...
Other Medicine Technology:Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 4
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: